Trials / Completed
CompletedNCT00398619
A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes
A Double-blind, Placebo Controlled Pharmacodynamic Study of the Effect of INCB013739 on Systemic and Adipose Tissue 11βHSD1 Activity in Obese, Insulin Resistant Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Incyte Corporation · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the investigational drug INCB013739 has an effect on systemic and adipose tissue 11-HSD1 activity in obese, insulin resistant subjects.
Detailed description
"Proprietary Information: Exploratory (Non-Confirmatory) Trial".
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | INCB13739 |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2006-11-14
- Last updated
- 2012-01-23
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00398619. Inclusion in this directory is not an endorsement.